Briggs W. Morrison
2016
In 2016, Briggs W. Morrison earned a total compensation of $872.7K as Chief Executive Officer at Syndax Pharmaceuticals, a 82% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $244,250 |
| Salary | $525,432 |
| Other | $3,000 |
| Total | $872,682 |
Morrison received $525.4K in salary, accounting for 60% of the total pay in 2016.
Morrison also received $100K in bonus, $244.3K in non-equity incentive plan and $3K in other compensation.
Rankings
In 2016, Briggs W. Morrison's compensation ranked 8,883rd out of 14,075 executives tracked by ExecPay. In other words, Morrison earned more than 36.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,883 out of 14,075 | 37th |
Division Manufacturing | 3,441 out of 5,486 | 37th |
Major group Chemicals And Allied Products | 1,168 out of 1,900 | 39th |
Industry group Drugs | 920 out of 1,543 | 40th |
Industry Pharmaceutical Preparations | 733 out of 1,173 | 38th |
Source: SEC filing on April 10, 2018.
Morrison's colleagues
We found two more compensation records of executives who worked with Briggs W. Morrison at Syndax Pharmaceuticals in 2016.
News
Syndax Pharmaceuticals CEO Briggs Morrison's 2021 pay jumps 80% to $3.9M
March 29, 2022
Syndax Pharmaceuticals CFO Daphne Karydas receives $3.1M in 2020
April 1, 2021
Syndax Pharmaceuticals COO Michael Metzger's 2019 pay jumps 77% to $2.7M
April 29, 2020
Syndax Pharmaceuticals CEO Briggs Morrison's 2018 pay jumps 24% to $2.1M
April 30, 2019